Rebekah Gallaugher
Nurse Practitioner · Chillicothe, OHNPI 1093217408
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Bayer at 47.4% of the total. Reporting peaked in 2023 at $822 and has fallen 55.1% since, to $369 in 2025. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$936
- Amgen$303
- AstraZeneca$178
- Ardelyx, Inc.$75
- OPKO Pharmaceuticals, LLC$74
- Novo Nordisk$50
- plus $359 from 15 others
What the payments were for
- Food & beverage$1,89296%
- Education$844%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 60 | $936 |
| Amgen | 12 | $303 |
| AstraZeneca(2 entities) | 9 | $178 |
| Ardelyx, Inc. | 4 | $75 |
| OPKO Pharmaceuticals, LLC | 4 | $74 |
| Novo Nordisk | 2 | $50 |
| Mallinckrodt Hospital Products Inc. | 2 | $50 |
| Ultragenyx Pharmaceutical Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Boehringer Ingelheim | 1 | $29 |
| Lilly USA, LLC | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $20 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Renalytix AI, Inc. | 1 | $17 |
| Nxstage Medical, Inc. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $15 |
| Travere Therapeutics, Inc. | 6 | $9 |
How this compares
$1,975 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 32 | $3,877 |
| Calcium Acetate | 27 | $1,652 |
| Midodrine Hcl | 27 | $589 |
| Hydralazine Hcl | 20 | $278 |
| Lisinopril | 20 | $227 |
| Furosemide | 12 | $106 |
| Carvedilol | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Chillicothe
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.